Davangere Devanand, M.D.
Professor of Clinical Psychiatry and Neurology
Director, DIvision of Geriatric Psychiatry,
New York State Psychiatric Institute
Co-Director, Memory Disorders Center,
New York Presbyterian Hospital
Co-Director, Adult and Late Life Depression Clinic,
Dr. D. P. Devanand is Professor of Clinical Psychiatry and Neurology at the College of Physicians and Surgeons, Columbia University. He completed medical school at Christian Medical College, Vellore, in India, and trained in psychiatry at the National Institute of Mental Health and Neurosciences, Bangalore, India.
He began psychiatry residency training at S.U.N.Y. Upstate Medical Center, Syracuse, and completed it at Yale University School of Medicine. He then did a clinical research fellowship in Biological Psychiatry at Columbia University, and has continued on the faculty at Columbia University since 1987.
Currently, he is Director of the Division of Geriatric Psychiatry, Co-Director of the Memory Disorders Center, and Co-Director of the Adult and Late Life Depression Clinic at the New York State Psychiatric Institute. His research studies involve Alzheimer’s disease, geriatric depression and electroconvulsive therapy. His research has helped define the clinical features and treatment response in elderly patients with chronic mild to moderate depression, or dysthymic disorder.
He pioneered studies on the interface between depression and cognitive impairment in the elderly, and he is also known for his research into early diagnostic markers of Alzheimer’s disease and the treatment of psychosis and agitation in Alzheimer’s disease. He has been principal investigator on several research grants from the National Institute of Aging and the National Institute of Mental Health. He has also been funded by the Alzheimer’s Association, NARSAD, the Dana Foundation, and the Department of Defense.
He has published over 225 research papers and articles, and is the author of three books, including The Memory Program.
Medical School: Christian Medical College, Vellore, M.B.B.S., 1979
Doctoral Degree: State University of New York, M.D., 1981
Internship: SUNY Upstate Medical Center, Psychiatry Residency, 1980 - 1982
Residency: Yale, Psychiatry Residency, 1982 - 1984
Fellowship: Columbia University, Research Fellowship, 1985 - 1987
Board Certifications: American Board of Psychiatry and Neurology 1985
Subspeciality Certifications: Geriatric Psychiatry sub-specialty 1991, re-certified 2009
• Neuropsychiatry/Cognitive Disorders
• Depressive Disorders
Click here for Dr. Devanand's Clinical Trials
NYS Psychiatric Institute
Room 2726 Unit/Box:126
1051 Riverside Drive
New York, NY 10032
1. Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R : Olfactory deficits in mild cognitive impairment predict Alzheimer's disease on follow-up. . American Journal of Psychiatry 2000;157: 1399-1405
1. Devanand DP, Pelton GH, Marston K, Camacho Y, Roose SP, Stern Y, Sackeim HA : Sertraline treatment of elderly patients with depression and cognitive impairment. . Int J Geriatr Psychiatry 2003;18: 123-130
1. Devanand DP, Pradhaban G, Khandji A, Tabert MH, De Santi S, Segal S, Liu X, Pelton GH, Honig L, Mayeux R, Stern Y, de Leon, M: Hippocampal and entorhinal atrophy in the prediction of MCI conversion to Alzheimer’s disease.. Neurology 2007;68: 828-836
1. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH: Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biological Psychiatry 2008;64: 871-879
1. Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B: Relapse risk after discontinuation of risperidone in Alzheimer’s disease.. New England Journal of Medicine 2012;367: 1497-1507